Добавил:
Sekretar
kiopkiopkiop18@yandex.ru
t.me/Prokururor I Вовсе не секретарь, но почту проверяю
Опубликованный материал нарушает ваши авторские права? Сообщите нам.
Вуз:
Предмет:
Файл:Ординатура / Хирургия / Библиотека им академика М.И. Перельмана / Книга_2589_Библиотеки_им_академика_М_И_Перельмана
.pdf
156
https://t.me/medicina_free
4. Blunt trauma with choroidal rupture
[88].
5. Degenerative myopia
6. Inammatory choroidal neovascular
membranes
(a) Toxoplasmic retinochoroiditis
(b) Tubercular serpiginous like
choroiditis
(c) VKH disease
(d) Sarcoid uveitis
(e) Multifocal choroidites with
panuveitis
(f) Punctate inner choroidopathy
(g) Presumed ocular histoplasmosis
syndrome (POHS)
7. Angioid streaks
8. Choroidal osteoma
9. Choroidal melanoma
10. Globe perforation during retrobulbar
anaesthesia injection [89].
References
1. Spaide RF, Jaffe GJ, Sarraf D, Freund KB, Sadda
SR, Staurenghi G, Waheed NK, Chakravarthy U,
Rosenfeld PJ, Holz FG, Souied EH, Cohen SY,
Querques G, Ohno-Matsui K, Boyer D, Gaudric A,
Blodi B, Baumal CR, Li X, Coscas GJ, Brucker A,
Singerman L, Luthert P, Schmitz-Valckenberg S,
Schmidt-Erfurth U, Grossniklaus HE, Wilson DJ,
Guymer R, Yannuzzi LA, Chew EY, Csaky K, Monés
JM, Pauleikhoff D, Tadayoni R, Fujimoto J.Consensus
nomenclature for reporting neovascular age-related
macular degeneration data: consensus on Neovascular
Age-Related Macular Degeneration Nomenclature
Study Group. Ophthalmology. 2020;127(5):616–36.
https://doi.org/10.1016/j.ophtha.2019.11.004. Epub
2019 Nov 14. Erratum in: Ophthalmology. 2020
Oct;127(10):1434-1435. PMID: 31864668.
2. van Leeuwen R, Chakravarthy U, Vingerling JR,
Brussee C, Hooghart AJ, Mulder PG, de Jong
PT.Grading of age-related maculopathy for epidemiological studies: is digital imaging as good as 35-mm
lm? Ophthalmology. 2003;110(8):1540–4. https://
doi.org/10.1016/S0161- 6420(03)00501- 3. PMID:
12917169.
3. Colijn JM, Buitendijk GHS, Prokofyeva E,
Alves D, Cachulo ML, Khawaja AP, CougnardGregoire A, Merle BMJ, Korb C, Erke MG, Bron
A, Anastasopoulos E, Meester-Smoor MA, Segato
T, Piermarocchi S, de Jong PTVM, Vingerling JR,
7 Subretinal/Submacular Haemorrhage
Topouzis F, Creuzot-Garcher C, Bertelsen G, Pfeiffer
N, Fletcher AE, Foster PJ, Silva R, Korobelnik JF,
Delcourt C, Klaver CCW, EYE-RISK Consortium;
European Eye Epidemiology (E3) Consortium.
Prevalence of age-related macular degeneration in
Europe: the past and the future. Ophthalmology.
2017;124(12):1753–63. https://doi.org/10.1016/j.
ophtha.2017.05.035. Epub 2017 Jul 14. PMID:
28712657; PMCID: PMC5755466.
4. Li JQ, Welchowski T, Schmid M, Mauschitz MM,
Holz FG, Finger RP. Prevalence and incidence of
age-related macular degeneration in Europe: a systematic review and meta-analysis. Br J Ophthalmol.
2020;104(8):1077–84. https://doi.org/10.1136/
bjophthalmol- 2019- 314422. Epub 2019 Nov 11.
PMID: 31712255.
5. Mauschitz MM, Finger RP. Age-related macular
degeneration and cardiovascular diseases: revisiting the common soil theory. Asia Pac J Ophthalmol
(Phila). 2022;11(2):94–9. https://doi.org/10.1097/
APO.0000000000000496. Epub 2022 Feb 23. PMID:
35213420.
6. Merle BMJ, Colijn JM, Cougnard-Grégoire A, de
Koning-Backus APM, Delyfer MN, Kiefte-de Jong
JC, Meester-Smoor M, Féart C, Verzijden T, Samieri
C, Franco OH, Korobelnik JF, Klaver CCW, Delcourt
C, EYE-RISK Consortium. Mediterranean diet and
incidence of advanced age-related macular degeneration: the EYE-RISK consortium. Ophthalmology.
2019;126(3):381–90. https://doi.org/10.1016/j.
ophtha.2018.08.006. Epub 2018 Aug 13. PMID:
30114418.
7. Mauschitz MM, Schmitz MT, Verzijden T, Schmid
M, Thee EF, Colijn JM, Delcourt C, CougnardGrégoire A, Merle BMJ, Korobelnik JF, Gopinath B,
Mitchell P, Elbaz H, Schuster AK, Wild PS, Brandl
C, Stark KJ, Heid IM, Günther F, Peters A, Klaver
CCW, Finger RP, European Eye Epidemiology (E3)
Consortium. Physical activity, incidence, and progression of age-related macular degeneration: a multicohort study. Am J Ophthalmol. 2022;236:99–106.
https://doi.org/10.1016/j.ajo.2021.10.008. Epub 2021
Oct 22. PMID: 34695401.
8. Fernandez AB, Ballard KD, Wong TY, Guo M,
McClelland RL, Burke G, Cotch MF, Klein B,
Allison M, Klein R. Age-related macular degeneration and progression of coronary artery calcium: the
multi-ethnic study of atherosclerosis. PLoS One.
2018;13(7):e0201000. https://doi.org/10.1371/
journal.pone.0201000. PMID: 30020999; PMCID:
PMC6051657.
9. Ikram MK, Mitchell P, Klein R, Sharrett AR,
Couper DJ, Wong TY. Age-related macular degeneration and long-term risk of stroke subtypes.
Stroke. 2012;43(6):1681–3. https://doi.org/10.1161/
STROKEAHA.112.654632. Epub 2012 Apr 24.
PMID: 22535267; PMCID: PMC3361598.
10. Anderson DH, Radeke MJ, Gallo NB, Chapin EA,
Johnson PT, Curletti CR, Hancox LS, Hu J, Ebright
JN, Malek G, Hauser MA, Rickman CB, Bok D,

References
https://t.me/medicina_free
157
Hageman GS, Johnson LV. The pivotal role of the
complement system in ageing and age-related macular
degeneration: hypothesis re-visited. Prog Retin Eye
Res. 2010;29(2):95–112. https://doi.org/10.1016/j.
preteyeres.2009.11.003. Epub 2009 Dec 2. PMID:
19961953; PMCID: PMC3641842.
11. Edwards AO, Ritter R 3rd, Abel KJ, Manning A,
Panhuysen C, Farrer LA. Complement factor H
polymorphism and age-related macular degeneration. Science. 2005;308(5720):421–4. https://doi.
org/10.1126/science.1110189. Epub 2005 Mar 10.
PMID: 15761121.
12. Haines JL, Hauser MA, Schmidt S, Scott WK, Olson
LM, Gallins P, Spencer KL, Kwan SY, Noureddine
M, Gilbert JR, Schnetz-Boutaud N, Agarwal A, Postel
EA, Pericak-Vance MA. Complement factor H variant increases the risk of age-related macular degeneration. Science. 2005;308(5720):419–21. https://doi.
org/10.1126/science.1110359. Epub 2005 Mar 10.
PMID: 1576112.
13. Klein RJ, Zeiss C, Chew EY, Tsai JY, Sackler RS,
Haynes C, Henning AK, SanGiovanni JP, Mane
SM, Mayne ST, Bracken MB, Ferris FL, Ott J,
Barnstable C, Hoh J.Complement factor H polymorphism in age-related macular degeneration. Science.
2005;308(5720):385–9. https://doi.org/10.1126/sci-
ence.1109557. Epub 2005 Mar 10. PMID: 15761122;
PMCID: PMC1512523.
14. Seddon JM, Francis PJ, George S, Schultz DW,
Rosner B, Klein ML.Association of CFH Y402H and
LOC387715 A69S with progression of age-related
macular degeneration. JAMA. 2007;297(16):1793–
800. https://doi.org/10.1001/jama.297.16.1793.
Erratum in: JAMA (2007) 297(23):2585. PMID:
1745682.
15. Strunz T, Kiel C, Sauerbeck BL, Weber
BHF. Learning from fteen years of genome-wide
association studies in age-related macular degeneration. Cells. 2020;9(10):2267. https://doi.org/10.3390/
cells9102267. PMID: 33050425; PMCID:
PMC7650698.
16. Micklisch S, Lin Y, Jacob S, etal. Age-related macular
degeneration associated polymorphism rs10490924in
ARMS2 results in deciency of a complement activator. J Neuroinammation. 2017;14:4. https://doi.
org/10.1186/s12974- 016- 0776- 3.
17. Rozing MP, Durhuus JA, Krogh Nielsen M, Subhi Y,
Kirkwood TB, Westendorp RG, Sørensen TL.Agerelated macular degeneration: a two-level model
hypothesis. Prog Retin Eye Res. 2020;76:100825.
https://doi.org/10.1016/j.preteyeres.2019.100825.
Epub 2019 Dec 30. PMID: 31899290.
18. Spaide RF, Ooto S, Curcio CA.Subretinal drusenoid
deposits AKA pseudodrusen. Surv Ophthalmol.
2018;63(6):782–815. https://doi.org/10.1016/j.sur-
vophthal.2018.05.005. Epub 2018 May 31. PMID:
29859199.
19. Nassisi M, Tepelus T, Nittala MG, Sadda
SR. Choriocapillaris ow impairment predicts the
development and enlargement of drusen. Graefes
Arch Clin Exp Ophthalmol. 2019;257(10):2079–85.
https://doi.org/10.1007/s00417- 019- 04403- 1. Epub
2019 Jul 1. PMID: 31263948.
20. Gass JD. Drusen and disciform macular detachment and degeneration. Trans Am Ophthalmol
Soc. 1972;70:409–36. PMID: 4663679; PMCID:
PMC1310465.
21. Gass JD, Agarwal A, Lavina AM, Tawansy
KA. Focal inner retinal hemorrhages in patients
with drusen: an early sign of occult choroidal
neovascularization and chorioretinal anastomosis. Retina. 2003;23(6):741–51. https://doi.
org/10.1097/00006982- 200312000- 00001. PMID:
14707822.
22. Soubrane G, Coscas G.Discussion. Ophthalmology.
2000;107(4):753–4. https://doi.org/10.1016/
S0161- 6420(00)00010- 5.
23. Yannuzzi LA, Negrão S, Iida T, Carvalho C,
Rodriguez-Coleman H, Slakter J, Freund KB,
Sorenson J, Orlock D, Borodoker N.Retinal angiomatous proliferation in age-related macular degeneration. Retina. 2001;21(5):416–34. https://doi.
org/10.1097/00006982- 200110000- 00003. PMID:
11642370.
24. Yannuzzi LA, Slakter JS, Sorenson JA, Guyer DR,
Orlock DA. Digital indocyanine green videoangiography and choroidal neovascularization. Retina.
1992;12(3):191–223. PMID: 1384094.
25. Hanutsaha P, Guyer DR, Yannuzzi LA, Naing A,
Slakter JS, Sorenson JS, Spaide RF, Freund KB,
Feinsod M, Orlock DA. Indocyanine-green videoangiography of drusen as a possible predictive indicator of exudative maculopathy. Ophthalmology.
1998;105(9):1632–6. https://doi.org/10.1016/S0161-
6420(98)99030- 3. PMID: 9754169.
26. de Oliveira Dias JR, Zhang Q, Garcia JMB, Zheng
F, Motulsky EH, Roisman L, Miller A, Chen CL,
Kubach S, de Sisternes L, Durbin MK, Feuer W,
Wang RK, Gregori G, Rosenfeld PJ.Natural history
of subclinical neovascularization in nonexudative
age-related macular degeneration using swept-source
OCT angiography. Ophthalmology. 2018;125(2):255–
66. https://doi.org/10.1016/j.ophtha.2017.08.030.
Epub 2017 Sep 28. PMID: 28964581.
27. Sharma A, Cheung CMG, Arias-Barquet L,
Ozdek S, Parachuri N, Kumar N, Hilely A, Zur D,
Loewenstein A, Vella G, Bandello F, Querques
G. Fluid-based visual prognostication in type 3
macular neovascularization- ip- 3 study. Retina.
2022;42(1):107–13. https://doi.org/10.1097/
IAE.0000000000003261. PMID: 34255761.
28. Kleiner RC, Brucker AJ, Johnston RL. The posterior
uveal bleeding syndrome. Retina. 1990;10(1):9–17.
PMID: 2343198.
29. Yannuzzi LA, Sorenson J, Spaide RF, Lipson
B. Idiopathic polypoidal choroidal vasculopathy
(IPCV). Retina. 1990;10(1):1–8. PMID: 1693009.
30. Uyama M, Wada M, Nagai Y, Matsubara T,
Matsunaga H, Fukushima I, Takahashi K, Matsumura
M. Polypoidal choroidal vasculopathy: natural his-

158
https://t.me/medicina_free
7 Subretinal/Submacular Haemorrhage
tory. Am J Ophthalmol. 2002;133(5):639–48. https://
doi.org/10.1016/s0002- 9394(02)01404- 6. PMID:
11992861.
31. Sho K, Takahashi K, Yamada H, Wada M, Nagai
Y, Otsuji T, Nishikawa M, Mitsuma Y, Yamazaki
Y, Matsumura M, Uyama M. Polypoidal choroidal vasculopathy: incidence, demographic features, and clinical characteristics. Arch Ophthalmol.
2003;121(10):1392–6. https://doi.org/10.1001/
archopht.121.10.1392. PMID: 14557174.
32. Yannuzzi LA, Ciardella A, Spaide RF, Rabb M,
Freund KB, Orlock DA.The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy.
Arch Ophthalmol. 1997;115(4):478–85. https://doi.
org/10.1001/archopht.1997.01100150480005. PMID:
9109756.
33. Corvi F, Chandra S, Invernizzi A, Pace L, Viola F,
Sivaprasad S, Staurenghi G, Cheung CMG, Teo
KYC.Multimodal imaging comparison of polypoidal
choroidal vasculopathy between Asian and Caucasian
populations. Am J Ophthalmol. 2022;234:108–16.
https://doi.org/10.1016/j.ajo.2021.08.006. Epub 2021
Aug 24. PMID: 34450112.
34. Tsujikawa A, Sasahara M, Otani A, Gotoh N,
Kameda T, Iwama D, Yodoi Y, Tamura H, Mandai M,
Yoshimura N. Pigment epithelial detachment in polypoidal choroidal vasculopathy. Am J Ophthalmol.
2007;143(1):102–11. https://doi.org/10.1016/j.
ajo.2006.08.025. Epub 2006 Sep 28. PMID:
17101112.
35. Kramer M, Mimouni K, Priel E, Yassur Y, Weinberger
D.Comparison of uorescein angiography and indocyanine green angiography for imaging of choroidal
neovascularization in hemorrhagic age-related macular degeneration. Am J Ophthalmol. 2000;129(4):495–
500. https://doi.org/10.1016/s0002- 9394(99)00388- 8.
PMID: 10764859.
36. Tan CS, Ngo WK, Lim LW, Tan NW, Lim
TH.EVEREST study report 4: uorescein angiography features predictive of polypoidal choroidal vasculopathy. Clin Exp Ophthalmol. 2019;47(5):614–20.
https://doi.org/10.1111/ceo.13464. Epub 2019 Feb
10. PMID: 30652395; PMCID: PMC6767036.
37. Cheung CMG, Lai TYY, Ruamviboonsuk P, Chen
SJ, Chen Y, Freund KB, Gomi F, Koh AH, Lee WK,
Wong TY. Polypoidal choroidal vasculopathy: denition, pathogenesis, diagnosis, and management.
Ophthalmology. 2018;125(5):708–24. https://doi.
org/10.1016/j.ophtha.2017.11.019. Epub 2018 Jan 10.
PMID: 29331556.
38. Takayama K, Ito Y, Kaneko H, Kataoka K, Sugita
T, Maruko R, Hattori K, Ra E, Haga F, Terasaki
H. Comparison of indocyanine green angiography and optical coherence tomographic angiography in polypoidal choroidal vasculopathy. Eye
(Lond). 2017;31(1):45–52. https://doi.org/10.1038/
eye.2016.232. Epub 2016 Nov 4. PMID: 27813526;
PMCID: PMC5233943.
39. Izumi T, Koizumi H, Maruko I, Hasegawa T,
Iida T. Optical coherence tomography angiog-
raphy ndings of classic choroidal neovascularization in polypoidal choroidal vasculopathy.
Retina. 2022;42(1):123–8. https://doi.org/10.1097/
IAE.0000000000003264. PMID: 34292224.
40. Ma ST, Huang CH, Chang YC, Lai TT, Hsieh YT,
Ho TC, Yang CM, Cheng CG, Yang CH. Clinical
features and prognosis of polypoidal choroidal vasculopathy with different morphologies of branching
vascular network on optical coherence tomography
angiography. Sci Rep. 2021;11(1):17848. https://
doi.org/10.1038/s41598- 021- 97340- 1. PMID:
34497317; PMCID: PMC8426494.
41. Yamagishi T, Koizumi H, Yamazaki T, Kinoshita
S. Fundus autouorescence in polypoidal choroidal
vasculopathy. Ophthalmology. 2012;119(8):1650–7.
https://doi.org/10.1016/j.ophtha.2012.02.016. Epub
2012 Apr 17. PMID: 22512987.
42. Tso MOM, Suarez MJ, Eberhart CG. Pathologic
study of early manifestations of polypoidal choroidal vasculopathy and pathogenesis of choroidal neo- vascularization. Am J Ophthalmol Case
Rep. 2017;11:176–80. https://doi.org/10.1016/j.
ajoc.2017.10.012. PMID: 30128371; PMCID:
PMC6097175.
43. Lafaut BA, Aisenbrey S, Van den Broecke C, BartzSchmidt KU, Heimann K. Polypoidal choroidal
vasculopathy pattern in age-related macular degeneration: a clinicopathologic correlation. Retina.
2000;20(6):650–4. https://doi.org/10.1097/00006982-
200011000- 00010. PMID: 11131419.
44. Liu G, Han L, Lu Y, Wang C, Ma L, Zhang P, Liu C, Lu
X, Ma Z.Clinicopathological study of the polypoidal
lesions of polypoidal choroidal vasculopathy. Graefes
Arch Clin Exp Ophthalmol. 2022;260(7):2369–77.
https://doi.org/10.1007/s00417- 021- 05525- 1. Epub
2022 Feb 11. PMID: 35147748.
45. Matsuoka M, Ogata N, Otsuji T, Nishimura T,
Takahashi K, Matsumura M. Expression of pigment epithelium derived factor and vascular
endothelial growth factor in choroidal neovascular
membranes and polypoidal choroidal vasculopathy.
Br J Ophthalmol. 2004;88(6):809–15. https://doi.
org/10.1136/bjo.2003.032466. PMID: 15148217;
PMCID: PMC1772169.
46. Baek J, Kim JH, Lee MY, Lee WK. Disease activity after development of large subretinal hemorrhage in polypoidal choroidal vasculopathy. Retina.
2018;38(10):1993–2000. https://doi.org/10.1097/
IAE.0000000000001817. PMID: 28834950.
47. Chung SE, Kang SW, Lee JH, Kim YT. Choroidal
thickness in polypoidal choroidal vasculopathy
and exudative age-related macular degeneration.
Ophthalmology. 2011;118(5):840–5. https://doi.
org/10.1016/j.ophtha.2010.09.012. Epub 2011 Jan 6.
PMID: 21211846.
48. Pang CE, Freund KB. Pachychoroid neovasculopathy. Retina. 2015;35(1):1–9. https://doi.org/10.1097/
IAE.0000000000000331. PMID: 25158945.
49. Wang TA, Chan WC, Tsai SH, etal. Clinical features
of pachyvessels associated with polypoidal choroidal

References
https://t.me/medicina_free
159
vasculopathy in chronic central serous chorioretinopathy. Sci Rep. 2021;11:13867. https://doi.org/10.1038/
s41598- 021- 93476- 2.
50. Warrow DJ, Hoang QV, Freund KB. Pachychoroid
pigment epitheliopathy. Retina. 2013;33(8):1659–72.
https://doi.org/10.1097/IAE.0b013e3182953df4.
PMID: 23751942.
51. Dansingani KK, Balaratnasingam C, Klufas MA,
Sarraf D, Freund KB.Optical coherence tomography
angiography of shallow irregular pigment epithelial
detachments in pachychoroid spectrum disease. Am J
Ophthalmol. 2015;160(6):1243–1254.e2. https://doi.
org/10.1016/j.ajo.2015.08.028. Epub 2015 Aug 28.
PMID: 26319161.
52. Shen M, Zhou H, Kim K, Bo Q, Lu J, Laiginhas R,
Jiang X, Yan Q, Iyer P, Trivizki O, Shi Y, de Sisternes
L, Durbin MK, Feuer W, Gregori G, Wang RK, Sun
X, Wang F, Yu SY, Rosenfeld PJ.Choroidal changes
in eyes with polypoidal choroidal vasculopathy
after anti-VEGF therapy imaged with swept-source
OCT angiography. Invest Ophthalmol Vis Sci.
2021;62(15):5. https://doi.org/10.1167/iovs.62.15.5.
PMID: 34860239; PMCID: PMC8648060.
53. Ma L, Li Z, Liu K, Rong SS, Brelen ME, Young
AL, Kumaramanickavel G, Pang CP, Chen H, Chen
LJ. Association of genetic variants with polypoidal choroidal vasculopathy: a systematic review
and updated meta-analysis. Ophthalmology.
2015;122(9):1854–65. https://doi.org/10.1016/j.
ophtha.2015.05.012. Epub 2015 Jun 13. PMID:
26081444.
54. Gemmy Cheung CM, Yeo I, Li X, Mathur R, Lee
SY, Chan CM, Wong D, Wong TY.Argon laser with
and without anti-vascular endothelial growth factor
therapy for extrafoveal polypoidal choroidal vasculopathy. Am J Ophthalmol. 2013;155(2):295–304.e1.
https://doi.org/10.1016/j.ajo.2012.08.002. Epub 2012
Oct 27. PMID: 23111181.
55. Wong CW, Cheung CM, Mathur R, Li X, Chan CM,
Yeo I, Wong E, Lee SY, Wong D, Wong TY.Three-year
results of polypoidal choroidal vasculopathy treated
with photodynamic therapy: retrospective study and
systematic review. Retina. 2015;35(8):1577–93.
https://doi.org/10.1097/IAE.0000000000000499.
PMID: 25719986.
56. Kim SW, Oh J, Oh IK, Huh K.Retinal pigment epithelial tear after half uence PDT for serous pigment epithelial detachment in central serous chorioretinopathy.
Ophthalmic Surg Lasers Imaging. 2009;40(3):300–3.
https://doi.org/10.3928/15428877- 20090430- 14.
PMID: 19485297.
57. Klais CM, Ober MD, Freund KB, Ginsburg LH,
Luckie A, Mauget-Faÿsse M, Coscas G, Gross NE,
Yannuzzi LA.Choroidal infarction following photodynamic therapy with verteporn. Arch Ophthalmol.
2005;123(8):1149–53. https://doi.org/10.1001/
archopht.123.8.1149. PMID: 16087856.
58. Lee WK, Iida T, Ogura Y, Chen SJ, Wong TY, Mitchell
P, Cheung GCM, Zhang Z, Leal S, Ishibashi T,
PLANET Investigators. Efcacy and safety of intra-
vitreal aibercept for polypoidal choroidal vasculopathy in the PLANET study: a randomized clinical trial.
JAMA Ophthalmol. 2018;136(7):786–93. https://doi.
org/10.1001/jamaophthalmol.2018.1804. Erratum in:
JAMA Ophthalmol. 2018 Jul 1;136(7):840. PMID:
29801063; PMCID: PMC6136040.
59. Ogura Y, Jaffe GJ, Cheung CMG, Kokame GT, Iida T,
Takahashi K, Lee WK, Chang AA, Monés J, D’Souza
D, Weissgerber G, Gedif K, Koh A.Efcacy and safety
of brolucizumab versus aibercept in eyes with polypoidal choroidal vasculopathy in Japanese participants
of HAWK. Br J Ophthalmol. 2022;106(7):994–9.
https://doi.org/10.1136/bjophthalmol- 2021- 319090.
Epub 2021 Jul 22. PMID: 34301613; PMCID:
PMC9234403.
60. Yanagi Y, Ting DSW, Ng WY, Lee SY, Mathur R,
Chan CM, Yeo I, Wong TY, Cheung GCM.Choroidal
vascular hyperpermeability as a predictor of treatment response for polypoidal choroidal vasculopathy. Retina. 2018;38(8):1509–17. https://doi.
org/10.1097/IAE.0000000000001758. PMID:
28704255.
61. Kim H, Lee SC, Kwon KY, Lee JH, Koh HJ, Byeon
SH, Kim SS, Kim M, Lee CS. Subfoveal choroidal
thickness as a predictor of treatment response to antivascular endothelial growth factor therapy for polypoidal choroidal vasculopathy. Graefes Arch Clin
Exp Ophthalmol. 2016;254(8):1497–503. https://doi.
org/10.1007/s00417- 015- 3221- x. Epub 2015 Dec 1.
PMID: 26626772.
62. Cho SC, Cho J, Park KH, Woo SJ.Massive submacular hemorrhage in polypoidal choroidal vasculopathy versus typical neovascular age-related macular
degeneration. Acta Ophthalmol. 2021;99(5):e706–14.
https://doi.org/10.1111/aos.14676. Epub 2020 Dec 2.
PMID: 33289345.
63. Cho JH, Ryoo NK, Cho KH, Park SJ, Park KH, Woo
SJ. Incidence rate of massive submacular hemorrhage and its risk factors in polypoidal choroidal
vasculopathy. Am J Ophthalmol. 2016;169:79–88.
https://doi.org/10.1016/j.ajo.2016.06.014. Epub 2016
Jun 16. PMID: 27318076.
64. Heriot W.Intravitreal gas and tPA: an outpatient procedure for subretinal haemorrhage. In: Vail vitrectomy meeting; 1996; Vail, CO.
65. Coll GE, Sparrow JR, Marinovic A, Chang S.Effect of
intravitreal tissue plasminogen activator on experimental subretinal hemorrhage. Retina. 1995;15(4):319–26.
https://doi.org/10.1097/00006982- 199515040- 00009.
PMID: 8545578.
66. Boone DE, Boldt HC, Ross RD, Folk JC, Kimura
AE.The use of intravitreal tissue plasminogen activator in the treatment of experimental subretinal hemorrhage in the pig model. Retina. 1996;16(6):518–24.
https://doi.org/10.1097/00006982- 199616060- 00009.
PMID: 9002136.
67. Johnson MW, Olsen KR, Hernandez E. Tissue plasminogen activator treatment of experimental subretinal hemorrhage. Retina. 1991;11(2):250–8. https://

160
https://t.me/medicina_free
7 Subretinal/Submacular Haemorrhage
doi.org/10.1097/00006982- 199111020- 00011.
PMID: 1925092.
68. Hassan AS, Johnson MW, Schneiderman TE,
Regillo CD, Tornambe PE, Poliner LS, Blodi BA,
Elner SG. Management of submacular hemorrhage with intravitreous tissue plasminogen activator injection and pneumatic displacement.
Ophthalmology. 1999;106(10):1900–6; discussion
1906–7. PMID: 10519583. https://doi.org/10.1016/
S0161- 6420(99)90399- 8.
69. Chen CY, Hooper C, Chiu D, Chamberlain M, Karia
N, Heriot WJ. Management of submacular hemorrhage with intravitreal injection of tissue plasminogen
activator and expansile gas. Retina. 2007;27(3):321–8.
https://doi.org/10.1097/01.iae.0000237586.48231.75.
PMID: 17460587.
70. Kadonosono K, Arakawa A, Yamane S, Inoue M,
Yamakawa T, Uchio E, Yanagi Y. Displacement of
submacular hemorrhages in age-related macular
degeneration with subretinal tissue plasminogen activator and air. Ophthalmology. 2015;122(1):123–8.
https://doi.org/10.1016/j.ophtha.2014.07.027. Epub
2014 Sep 4. PMID: 25200400.
71. Sharma S, Kumar JB, Kim JE, Thordsen J, Dayani P,
Ober M, Mahmoud TH.Pneumatic displacement of
submacular hemorrhage with subretinal air and tissue
plasminogen activator: initial United States experience. Ophthalmol Retina. 2018;2(3):180–6. https://
doi.org/10.1016/j.oret.2017.07.012. Epub 2017 Sep
28. PMID: 31047581.
72. Chakraborty D, Sheth JU, Mondal S, Boral S.Role
of intravitreal brolucizumab with intravitreal rtPA
and pneumatic displacement for submacular hemorrhage: a case series. Am J Ophthalmol Case
Rep. 2022;25:101390. https://doi.org/10.1016/j.
ajoc.2022.101390. PMID: 35198814; PMCID:
PMC8841994.
73. Guthoff R, Guthoff T, Meigen T, Goebel
W.Intravitreous injection of bevacizumab, tissue plasminogen activator, and gas in the treatment of submacular hemorrhage in age-related macular degeneration.
Retina. 2011;31(1):36–40. https://doi.org/10.1097/
IAE.0b013e3181e37884. PMID: 20921929.
74. Klettner A, Puls S, Treumer F, Roider J, Hillenkamp
J. Compatibility of recombinant tissue plasminogen
activator and bevacizumab co-applied for neovascular age-related macular degeneration with submacular
hemorrhage. Arch Ophthalmol. 2012;130(7):875–81.
https://doi.org/10.1001/archophthalmol.2012.120.
PMID: 22410628.
75. Hillenkamp J, Surguch V, Framme C, Gabel VP,
Sachs HG. Management of submacular hemorrhage
with intravitreal versus subretinal injection of recombinant tissue plasminogen activator. Graefes Arch
Clin Exp Ophthalmol. 2010;248(1):5–11. https://doi.
org/10.1007/s00417- 009- 1158- 7. Epub 2009 Aug 11.
PMID: 19669780.
76. Kimura S, Morizane Y, Hosokawa M, Shiode Y,
Kawata T, Doi S, Matoba R, Hosogi M, Fujiwara
A, Inoue Y, Shiraga F. Submacular hemorrhage in
polypoidal choroidal vasculopathy treated by vitrectomy and subretinal tissue plasminogen activator.
Am J Ophthalmol. 2015;159(4):683–9. https://doi.
org/10.1016/j.ajo.2014.12.020. Epub 2014 Dec 30.
PMID: 25555798.
77. van Zeeburg EJ, van Meurs JC. Literature review
of recombinant tissue plasminogen activator used
for recent-onset submacular hemorrhage displacement in age-related macular degeneration.
Ophthalmologica. 2013;229(1):1–14. https://doi.
org/10.1159/000343066. Epub 2012 Oct 12. PMID:
23075629.
78. de Jong JH, van Zeeburg EJ, Cereda MG, van
Velthoven ME, Faridpooya K, Vermeer KA, van
Meurs JC. Intravitreal versus subretinal administration of recombinant tissue plasminogen activator
combined with gas for acute submacular hemorrhages
due to age-related macular degeneration: an exploratory prospective study. Retina. 2016;36(5):914–25.
https://doi.org/10.1097/IAE.0000000000000954.
PMID: 26807631.
79. Grohmann C, Dimopoulos S, Bartz-Schmidt KU,
Schindler P, Katz T, Spitzer MS, Skevas C.Surgical
management of submacular hemorrhage due to
n-AMD: a comparison of three surgical methods. Int
J Retina Vitreous. 2020;6:27. https://doi.org/10.1186/
s40942- 020- 00228- x. PMID: 32637155; PMCID:
PMC7331168.
80. Iglicki M, Khoury M, Melamud JI, Donato L, Barak
A, Quispe DJ, Zur D, Loewenstein A.Naïve subretinal
haemorrhage due to neovascular age-related macular
degeneration. Pneumatic displacement, subretinal
air, and tissue plasminogen activator: subretinal vs
intravitreal aibercept-the native study. Eye (Lond).
2023;37:1659. https://doi.org/10.1038/s41433- 022-
02222- z. Epub ahead of print. PMID: 36038720.
81. Erdogan G, Kirmaci A, Perente I, Artunay
O. Gravitational displacement of submacular haemorrhage in patients with age-related macular disease. Eye (Lond). 2020;34(6):1136–41. https://doi.
org/10.1038/s41433- 019- 0720- 8. Epub 2019 Dec 2.
PMID: 31792350; PMCID: PMC7253466.
82. Wu TT, Kung YH, Hong MC. Vitreous hemorrhage
complicating intravitreal tissue plasminogen activator and pneumatic displacement of submacular
hemorrhage. Retina. 2011;31(10):2071–7. https://
doi.org/10.1097/IAE.0b013e31822528c8. PMID:
21817964.
83. Lim JH, Han YS, Lee SJ, Nam KY.Risk factors for
breakthrough vitreous hemorrhage after intravitreal
tissue plasminogen activator and gas injection for submacular hemorrhage associated with age related macular degeneration. PLoS One. 2020;15(12):e0243201.
https://doi.org/10.1371/journal.pone.0243201. PMID:
33270725; PMCID: PMC7714180.
84. Hua HU, Rayess N, Moshfeghi AA. Acute promyelocytic leukemia with sudden vision loss. JAMA
Ophthalmol. 2020;138(2):206–7. https://doi.
org/10.1001/jamaophthalmol.2019.4838. PMID:
31804661.

References
https://t.me/medicina_free
161
85. Lee C, Hwang Y-S. Hemorrhagic retinal detachment in acute promyelocytic leukemia. Taiwan J
Ophthalmol. 2013;3:123–5. https://doi.org/10.1016/j.
tjo.2012.12.006.
86. Hu HH, Zhu XY, Xie ZG, Chen F. Multimodal
imaging of spontaneous subretinal hemorrhage in
a young male: a case report. BMC Ophthalmol.
2020;20(1):374. https://doi.org/10.1186/s12886- 020-
01634- 3. PMID: 32962682; PMCID: PMC7510117.
87. Sakaguchi S, Muraoka Y, Kadomoto S, Ooto S,
Murakami T, Nishigori N, Ishikura M, Miyake M,
Miyata M, Uji A, Tsujikawa A. Three-dimensional
locations of ruptured retinal arterial macroaneurysms
and their associations with the visual prognosis.
Sci Rep. 2022;12(1):503. https://doi.org/10.1038/
s41598- 021- 04500- 4. PMID: 35017582; PMCID:
PMC8752622.
88. Chen KJ, Sun MH, Sun CC, Wang NK, Hou CH, Wu
AL, Wu WC, Lai CC. Traumatic maculopathy with
massive subretinal hemorrhage after closed-globe
injuries: associated ndings, management, and visual
outcomes. Ophthalmol Retina. 2019;3(1):53–60.
https://doi.org/10.1016/j.oret.2018.08.007. Epub
2018 Aug 25. PMID: 30935658.
89. Dai Y, Sun T, Gong JF. Inadvertent globe penetration during retrobulbar anesthesia: a case report.
World J Clin Cases. 2021;9(8):2001–7. https://doi.
org/10.12998/wjcc.v9.i8.2001. PMID: 33748253;
PMCID: PMC7953384.

Retinal Arteriolar Changes
https://t.me/medicina_free
inHypertension
andArteriolosclerosis
8
8.1 Structural Considerations
oftheBlood Vessels
The cardiovascular system in the body is highly
organized into the arteries, the capillaries, and the
veins. The largest of the arteries is the aorta and
its branches that carry oxygenated blood from the
left ventricle of the heart (except the pulmonary
vein that carries oxygenated blood from the lungs
to the left atrium), the medium size arteries carry
the blood to various parts and organs of the body.
The small arteries distribute it further to every
part of the target organs and tissues by subdividing it into arterioles. Diffusion of oxygen and
micronutrients occurs at the level of the arteriolar
end of the capillaries; the waste products enter
the intravascular space at the venous end of the
capillaries, which further organize into the progressively increasing size and nally drain into
the right atrium via the superior and inferior vena
cava. The veins carry the deoxygenated blood
except for the pulmonary artery, which carries
the deoxygenated blood from the right ventricle
to the lungs.
The arteries and the veins, irrespective of their
size, share the same structure: the outer tunica
adventitia, a tunica media, and a tunica intima.
The large arteries nearer the heart, such as the
aorta and the common carotid artery, have more
elastin per unit area than the muscular arteries. It
helps smoothen the high-pressure wave of blood
ow from the heart. The medium and small arteries, called muscular arteries, have more smooth
muscle cells than elastin because these arteries
have contractile properties, which help regulate
the blood supply to the target organ. There are
many functional and anatomical differences in
the elastic and muscular arteries, and the readers
are referred to an extensive discussion on the subject [1]. Muscular arteries also have internal and
external elastic lamina on either side of the tunica
media. The veins distinctly lack the elastic lamina and very few smooth muscle cells but have
unidirectional valves, especially in the leg veins,
as they carry blood against gravity.
The tunica intima consists of endothelial
cells. In the arteries, the endothelial cells are longer and oriented toward the blood ow, while in
the veins, these are rounder. The essential difference between the endothelial cells of the arteries
and veins is that the former controls the vascular
tone. At the same time, the latter is the site for
adherence and migration of phagocytes and lymphocytes into the organs. The endothelial cells in
the large and medium arteries are also the primary site of atherosclerosis. The tunica media
consists of smooth muscle cells and elastic
bres. The tunica media is much thicker in the
arteries than the veins and is responsible for the
thickness of the wall of the vessels. The tunica
adventitia consists essentially of supporting
brous tissue [2].
© The Author(s), under exclusive license to Springer Nature Singapore Pte Ltd. 2023
A. Gupta et al., Ophthalmic Signs in Practice of Medicine,
https://doi.org/10.1007/978-981-99-7923-3_8
163

164
https://t.me/medicina_free
8 Retinal Arteriolar Changes inHypertension andArteriolosclerosis
8.1.1 Anatomical Considerations
oftheCentral Retinal Artery
andtheBlood Supply
oftheRetina
Our current understanding of the central retinal
artery (CRA) anatomy is based on extensive
dissections and studies by Dr. S.S. Hayreh [3].
The CRA, often the rst branch of the ophthalmic artery, is the primary source of blood supply to the inner retina. It rst traverses in orbit
and enters the optic nerve dural sheath to run in
the vaginal space before penetrating the optic
nerve about 10mm behind the globe to emerge
as a single artery in the centre of the optic nerve
head. As it emerges from the optic nerve head,
it divides into a superior and an inferior division, subdividing further to supply all four
quadrants of the retina. The retinal arterial system is end-arterial, and thus occlusion of any
branch of the arteriolar system will lead to retina ischaemia in the arteriole’s supply area. The
CRA is responsible for the supply to the inner
retina up to the outer limit of the inner nuclear
layer and accounts for only 20% of the blood
supply of the retina, the outer retina meeting its
oxygen and micronutrient requirements from
the choroid, which is fed by the posterior ciliary arteries. The posterior ciliary arteries are
also branches of the ophthalmic artery. In
nearly one third of the eyes, bilateral in nearly
15% of people, there may be an additional
small artery, the cilioretinal artery, a branch of
a posterior ciliary artery or the peripapillary
choroid that supplies a variable area of the
entire thickness of the macula. Rarely, a minor
arterial branch may arise from the CRA in the
optic nerve head before it emerges into the eye
and resembles a cilioretinal artery. The origin
of the cilioretinal artery is best demonstrated on
the fundus uorescein angiography as the dye
lls the cilioretinal artery synchronously with
the choroid a short while before the dye reaches
the CRA [4]. In the retina, only the CRA is
structurally a muscular artery, and like all such
arteries, the purpose of the CRA is to distribute
blood to the retina. These arteries are pulsatile;
even in the retina, the CRA pulsates synchronously with the cardiac rhythm. Pulsations of
the CRA at the optic disc before it divides are
an excellent sign and rule out raised intracranial
pressure.
Once the CRA divides into branches, they lose
their internal elastic lamina and thus anatomically are ‘arterioles’ [5]. The tunica media in the
human retinal arterioles near the optic disc consists of 5–7 layers of circumferentially oriented
smooth muscle cells, which in the peripheral retina get reduced to just 1–2 layers [6]. The arterioles cross the veins anteriorly in the retina, and at
the arteriovenous crossing (AV crossing), they
share a common adventitial sheath. The blood
supply of the retina is multitier. The central
500μm of the retina, the fovea centralis, is bereft
of any blood capillaries to allow unrestricted passage of light to the photoreceptors. The supercial and deep capillary plexus and the
interconnecting capillaries arise from the
branches of the CRA and supply oxygen and
micronutrients to the inner neurosensory retina
[from the retinal nerve bre layer (RNFL) to the
outer limit of the inner nuclear layer]. In contrast,
the outer neurosensory retina does not have any
blood supply of its own and is served by the choroid, one of the human body’s highest blood ow
tissues. Tight endothelial junctions in the retinal
blood vessels constitute the inner blood-retinal
barrier that does not allow the movement of macromolecules and cellular components into the
extravascular space in the neurosensory retina.
Moreover, the retinal arterial system is autoregulated to maintain a constant blood ow to the
inner retina. It can maintain perfusion of the inner
retina even if the intraocular pressure rises to
40–50mm of Hg [5]. The autoregulation of blood
ow at the level of the neuro-glial-vascular unit
controls the blood supply to meet the metabolic
requirements of the neural elements in the inner
retina. The fractal geometry of the retinal vessels
ensures a uniform blood ow and supply and
removal of the metabolites from the inner retina.
The retinal pigment epithelium (RPE), the
outermost layer of the retina, separates the neurosensory retina from the choroid. The blood supply in the choroid is multilayered and is under
autonomic control. The innermost layer of blood
vessels in the choroid consists of fenestrated capillaries, known as the choriocapillaris, a layer

8.1 Structural Considerations oftheBlood Vessels
https://t.me/medicina_free
165
which lies immediately below the RPE.The tight
gap junctions in the RPE provide the outer bloodretinal barrier and control the movement of
micronutrients into the retina. The choriocapillaris is fed by the middle Sattler and the outermost Haller layer of blood vessels that are
branches of the ciliary vessels.
8.1.2 Diameter oftheRetinal
Arterioles andTheir Fractal
Dimensions
The blood supply in the medium and small arteries and arterioles is diffusion limited. Therefore,
the diameter of these arteries and their branches
are governed by Murray’s principle of the cube
root of the blood ow these arteries are supposed
to convey to allow the principle of the optimal
use of space [7]. Thus, like the other natural phenomenon such as the branches of a tree or the
bronchial tree, the blood supply in the human
body and so also the retinal blood supply follow
a complex fractal geometry (cf. Euclidean geometry that follows straight lines) to maximize the
distribution of blood supply in a conned space.
Quantifying the various aspects of retinal vessel geometry, including their fractal dimensions,
is now possible using digital images or digitizing
them. The fractal dimension, a measure of the
complexity of the retinal vessels, has been calculated as 1.7 [8, 9]. Patients with Alzheimer’s disease have been found to show decreased arteriolar
and venular fractal dimensions [10] and, in
future, may become an important biomarker to
predict the onset of Alzheimer’s disease.
The diameter of the CRA in the optic nerve is
~200μm [4]. In recent years, retinal vessel size
and their fractal complexities have been studied
in the context of several systemic disorders,
including atherosclerosis, inammation, hypertension, coronary heart disease, and renal disease
[11]. Notably, the retinal blood vessel walls are
transparent in young people. Thus, on funduscopic examination/fundus imaging, only the
central red column is visible and documented.
Any measurement of the vessel diameter precludes the thickness of the peripheral clear
plasma ow and the wall of the vessel. The ves-
sels appear thicker on fundus uorescein angiography (FFA) because the dye occupies the entire
lumen of the vessels. Several platforms are available to analyze fundus pictures, and vessel diameter measurements may vary with each of these.
Most reliable, although not commonly available
everywhere, are adaptive optics camera systems
which yield high-resolution images by eliminating optical errors [12]. Adaptive optics photography has been used to measure the retinal arteriolar
wall thickness. It has been measured as
24.3±4.8μm [11]. It should be noted that the
retinal vessel diameter, especially of the retinal
arterioles, changes with the cardiac cycle,
increasing by almost 3.4% during the mid-cycle
and late systole and reducing back during the
diastole [11].
For a long time, increase in peripheral resistance from the narrowing of the peripheral arterioles has been speculated as a leading cause of
primary hypertension. This phenomenon has
been demonstrated in experimental models [13].
As the retinal arterioles share similar properties
with the peripheral arterioles, studying the retinal
arterioles’ diameter may provide clues to the
development of incident hypertension. Indeed,
that was the case in a prospective study of more
than 5000 middle-aged non-hypertensive patients
who were followed up, 14.4% (it varied from 8.9
to 22.3% in the lowest to the highest quintiles of
AV ratio) of patients who had narrowing of retinal arterioles at the start of the study developed
incident hypertension (≥140 systolic or ≥90mm
of Hg). The incidence of hypertension went up to
23% in those who also had focal narrowing of the
retinal arterioles, thus establishing the diffuse
narrowing and focal narrowing as important biomarkers that can predict the development of overt
hypertension in the near future [14]. However, it
is likely that the narrowing of the peripheral arterioles is a consequence of undiagnosed hypertension [15] and that at the time of recruitment to the
study, the patients already had hypertension that
was missed by the then criteria used for its diagnosis [14]. The criteria for diagnosing hypertension have changed since then. In patients with
stroke, hypertension-induced retinal microvascular changes, namely the diffuse or severe focal
narrowing of the retinal arterioles, severe arterio-

166
https://t.me/medicina_free
8 Retinal Arteriolar Changes inHypertension andArteriolosclerosis
venous nicking, and venous dilation, provide
valuable clues to the presence of cerebral microangiopathy that results in deep intracerebral
haemorrhage and lacunar infarcts [16].
8.2 Causes ofHypertension
The cause of hypertension varies depending upon
the age of the patients. Patients younger than 18
usually have an underlying renal parenchymal disease or Coarctation of the aorta. Those from 19 to
40 may have thyroid dysfunction or Takayasu’s
arteritis. Patients above 40 but below 65 may have
Polyarteritis nodosa or pheochromocytoma,
Cushing’s syndrome, hyperaldosteronism or even
obstructive sleep apnoea. Patients above 65 should
be suspected of atherosclerotic renal artery stenosis, renal failure or hypothyroidism [17].
8.3 Measuring Blood Pressure
Many physicians and trainees are unaware of the
correct technique for measuring blood pressure
in the clinic. All physicians must follow the
guidelines of the American Heart Association
(See Box 8.1). The denition of blood pressure is
changed from time to time as new evidence
becomes available. The current (as of 2020) denition and classication of hypertension are provided in Boxes 8.2 and 8.3.
Box 8.1 How to Measure Blood Pressure
1. Measure in both upper arms; if consistently
≥10mmHg in one arm, use that arm for
recording
2. >20mmHg needs further evaluation
3. No smoking, exercise or coffee for 30min
before the test
4. Record sitting for 3–5min, back supported
and feet at on the oor
5. No talking during the recording of the BP
6. Cuff of appropriate size, arm resting on a
table at heart level
7. Take three readings at the 1-min interval and
take a mean of the last two readings
Reference: American Heart Association
Inc.
Box 8.2 Denition of Hypertension
Hypertension is dened after 2–3 visits at
1–4weeks intervals depending upon the BP
Hypertension-clinic recording—
SBP≥140mmHg and/or DBP≥90mmHg
Hypertension home recording—
SBP≥135mmHg and/or DBP≥85mmHg
Normal BP—SBP≤130mmHg and/or
DBP≤85mmHg
Adapted from Verdecchia et al. [18]
with permission of the publishers
Box 8.3 Classication of Blood Pressure for
Adults
Classication BP
Normal <130 and <85
High normal 130–139 and/or 85–89
Stage 1 hypertension 140–159 and/or 90–99
Stage 2 hypertension ≥160 or ≥100
Isolated systolic
hypertension
Systolic BP (mmHg)
Diastolic BP (mmHg)
≥ 140 and <90
Source: Verdecchia etal. [18], with per-
mission of the publishers
8.4 Arteriosclerosis
andArteriolosclerosis
Arteriosclerosis is a generic term for stiffness of
the wall of the arteries and is a leading cause of
mortality worldwide. It is currently classied into
three types—(1) Atherosclerosis (Fig. 8.1), (2)
Monckeberg calcic medial sclerosis, and (3)
Arteriolosclerosis [19]. The large elastic and
medium muscular arteries are prone to develop
atherosclerosis and Monckeberg calcic medial
sclerosis (Internal elastic lamina calcication),
and discussion on these is beyond the scope of
this chapter. Arteriolosclerosis is seen at the level
of small arteries and arterioles. With advancing
age, the arterial walls lose elasticity and contractibility. The arteries become stiff due to increasing
bromuscular thickening or intimal hyalinosis
[19]. The resulting peripheral resistance is
responsible for hypertension and may be seen in
Соседние файлы в папке Библиотека им академика М.И. Перельмана
